BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Business

  Novaliq GmbH Appoints Friedrich Von Bohlen, PhD, As Chairman And Gerald Cagle, PhD, As New Member Of Novaliq’s Supervisory Board

  December 8, 2015

   · 

  1 min read
• Drug Development

  Cynapsus Therapeutics Announces Positive Data Presentations At World Congress On Parkinson’s Disease And Related Disorders Meeting

  December 8, 2015

   · 

  9 min read
• Tiziana Life Sciences Plc Release: Fund Raising

  December 8, 2015

   · 

  3 min read
• European Medicines Agency Grants Orphan Drug Designation To Debiopharm International SA’s IAP Inhibitor Debio 1143 In The Treatment Of Ovarian Cancer

  December 8, 2015

   · 

  1 min read
• Drug Development

  MGB Biopharma Limited Successfully Completes Phase I Clinical Trial With Oral MGB-BP-3 – A Truly Novel Antibiotic Targeting Clostridium Difficile Infections

  December 8, 2015

   · 

  2 min read
• Deals

  Luye Pharma Group Ltd. Buys Australian Hospital China For $688 Million

  December 8, 2015

   · 

  1 min read
• Pharm Country

  Edge Therapeutics To Participate In Guggenheim Securities 3rd Annual Healthcare Conference

  December 8, 2015

   · 

  2 min read
• Drug Development

  Therabron Therapeutics Announces Favorable Infant Outcomes With Six-Month Follow-Up Of A Phase 1b Recombinant Human CC10 Clinical Trial

  December 8, 2015

   · 

  4 min read
• Drug Development

  ContraVir Reports Key CMX157 Data At HEP DART 2015 Demonstrating Enhanced In Vitro Safety Profile Compared To Viread

  December 8, 2015

   · 

  3 min read
• Business

  S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) And Chong Kun Dang Pharmaceutical Corporation Announce Commercialization Agreement For Lorexys In South Korea For Treatment Of Hypoactive Sexual Desire Disorder (HSDD) In Women

  December 8, 2015

   · 

  3 min read